Home

Relapse

Alcohol Dependence, Schizophrenia

Read time: 3 min

Congress highlights

Decreasing relapse and rehospitalization in first-episode psychosis

More than 50% of people with first-episode psychosis (FEP) have comorbid substance use disorder (...

Read time: 3 min

The effects of antipsychotic dose reduction/discontinuation on long-term outcome in FEP patients

Patients with FEP often ask whether they can discontinue their medication after a period of...

Read time: 3 min

Innovation and tailored treatments drive improved outcomes in depression

We are a step closer to the early detection of antidepressant treatment failure, a paradigm shift...

Read time: 3 min

Treatment-resistant schizophrenia — mechanisms, awareness, and economic burden

One-third of individuals with schizophrenia develop treatment-resistant schizophrenia (TRS); and 70...

Read time: 5 min

Changing the course of schizophrenia: biology, psychology and livelihood

How to manage and mitigate some long-term problems associated with schizophrenia, and improve...

Digital technology and the patient experience - what are the opportunities and challenges of ‘mHealth’?

Read the full feature here.

Digital technology and the patient experience - what are the opportunities and challenges of ‘mHealth’?

Depression, Schizophrenia

Read time: 4 min

Can new technologies address old problems in mental health treatment?

Depression, Schizophrenia

Read time: 3 min

ICD-11: new and fit for clinical utility and consistency

The new ICD chapter on mental health and behavioral disorders is designed to offer guidelines to...

Read time: 4 min

Improving long-term outcomes in schizophrenia — translating evidence into practice

The long-term goals of treatment to optimize outcomes for patients with schizophrenia are relapse...

Read time: 3 min

Innovation and tailored treatments drive improved outcomes in depression

We are a step closer to the early detection of antidepressant treatment failure, a paradigm shift...

Read time: 5 min

Congress highlights

Digital technology and the patient experience - what are the opportunities and challenges of ‘mHealth’?

Digital technology has already transformed the way we work, but, maybe surprisingly, has yet to...

Read time: 3 min

Congress highlights

Urgent need to optimize treatment in major depression

Residual symptoms reduce the likelihood of return to pre-depression functioning and increase the...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country